You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-AKT1 (phospho S473) antibody (ab8932)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab8932? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab8932 has been referenced in 6 publications.

  1. Cima I et al. Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer. Proc Natl Acad Sci U S A 108:3342-7 (2011). IHC; Human. PubMed: 21300890
  2. Dupont J et al. FSH-stimulated PTEN activity accounts for the lack of FSH mitogenic effect in prepubertal rat Sertoli cells. Mol Cell Endocrinol 315:271-6 (2010). PubMed: 19778579
  3. Hager M et al. Increased activated Akt expression in renal cell carcinomas and prognosis. J Cell Mol Med 13:2181-8 (2009). PubMed: 18774962
  4. Jousan FD et al. Short-Term culture of in vitro produced bovine preimplantation embryos with insulin-like growth factor-i prevents heat shock-induced apoptosis through activation of the Phosphatidylinositol 3-Kinase/Akt pathway. Mol Reprod Dev 75:681-8 (2008). IF; Cow. PubMed: 18161856
  5. Shah T et al. Epidermal growth factor receptor expression and activation in neuroendocrine tumours. J Neuroendocrinol 18:355-60 (2006). PubMed: 16629834
  6. Volanti C et al. Distinct transduction mechanisms of cyclooxygenase 2 gene activation in tumour cells after photodynamic therapy. Oncogene 24:2981-91 (2005). PubMed: 15735712

Publishing research using ab8932? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"